vimarsana.com
Home
Live Updates
BioCardia, Inc. (BCDA) CEO Peter Altman on Q2 2022 Results -
BioCardia, Inc. (BCDA) CEO Peter Altman on Q2 2022 Results -
BioCardia, Inc. (BCDA) CEO Peter Altman on Q2 2022 Results - Earnings Call Transcript
BioCardia, Inc. (NASDAQ:NASDAQ:BCDA) Q2 2022 Earnings Conference Call August 10, 2022, 04:30 PM ET Company Participants Jules Abraham - IR, CORE IR Peter Altman - President and CEO David...
Related Keywords
Japan ,
United States ,
Canada ,
Yokohama ,
Kanagawa ,
Japanese ,
Canadian ,
David Mcclung ,
Kumar Raja ,
Peter Altman ,
Kumaraguru Raja ,
Jules Abraham ,
Michael Okunewitch ,
James Molloy ,
Company Participants ,
Centre For Medicare ,
Ministry Of Health ,
Alliance Global Partners ,
Nasdaq ,
University Of Wisconsin ,
Maxim Group ,
Biocardia Inc ,
European Union ,
Device Agency ,
Health Canada ,
Medicaid Services ,
Conference Call August ,
Quarter Conference ,
Investor Relations ,
Chief Executive Officer ,
Chief Financial ,
Institutional Review Board ,
Failure Trial ,
Therapy Heart Failure ,
Myocardial Ischemia Trial ,
Medical Device Agency ,
Therapy System ,
Brookline Capital ,
United States Medicare ,
Second Annual Acute Respiratory Distress Syndrome ,
Second Annual Art ,
Chronic Myocardial ,
Alliance Global ,